These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 36939981

  • 1. Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk.
    Abuzgaia AM, Elzagallaai AA, Mullowney T, Rieder MJ.
    Mol Diagn Ther; 2023 May; 27(3):395-403. PubMed ID: 36939981
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides.
    Elzagallaai AA, Koren G, Rieder MJ.
    J Clin Pharmacol; 2013 Jun; 53(6):626-32. PubMed ID: 23670648
    [Abstract] [Full Text] [Related]

  • 3. The controversy of drug hypersensitivity in patients with cystic fibrosis and review of the literature.
    Tugcu GD, Emiralioglu N, Yalcin E, Sahiner UM, Dogru D, Sekerel BE, Ozcelik U, Kiper N, Soyer O.
    Pediatr Allergy Immunol; 2022 Feb; 33(2):e13719. PubMed ID: 34907613
    [Abstract] [Full Text] [Related]

  • 4. The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study.
    Elzagallaai AA, Abuzgaia AM, Del Pozzo-Magaña BR, Loubani E, Rieder MJ.
    Front Pharmacol; 2022 Feb; 13():945545. PubMed ID: 36110527
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphocyte transformation test and cytokine detection assays: Determination of read out parameters for delayed-type drug hypersensitivity reactions.
    Srinoulprasert Y.
    J Immunol Methods; 2021 Sep; 496():113098. PubMed ID: 34216607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The association of CD4 lymphocyte count with drug hypersensitivity reaction to highly active antiretroviral therapy, trimethoprim sulfamethoxazole, and antitubercular agents in human immunodeficiency virus patients.
    Tarranza JLS, Ang MCD.
    Asia Pac Allergy; 2022 Jul; 12(3):e26. PubMed ID: 35966163
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses.
    Kowalik A, de Monestrol I, Sorjonen K, Brockow K, Gülen T.
    Br J Clin Pharmacol; 2022 Nov; 88(11):4845-4853. PubMed ID: 35671007
    [Abstract] [Full Text] [Related]

  • 10. The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients.
    Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, Mainguy C, Nicolas JF, Nosbaum A, Jubin V.
    Pediatr Allergy Immunol; 2020 May; 31(4):396-404. PubMed ID: 31880334
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Süleyman A, Tamay Z, Güler N.
    Pediatr Pulmonol; 2022 Nov; 57(11):2622-2628. PubMed ID: 35833362
    [Abstract] [Full Text] [Related]

  • 12. Hypersensitivity reactions to multiple anti-tuberculosis drugs.
    Shin HJ, Chang JS, Kim MS, Koh BG, Park HY, Kim TO, Park CK, Oh IJ, Kim YI, Lim SC, Kim YC, Koh YI, Kwon YS.
    PLoS One; 2021 Nov; 16(2):e0246291. PubMed ID: 33539388
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of drug hypersensitivity reactions using 6-year national health insurance claim data from Korea.
    Han J, Ye YM, Lee S.
    Int J Clin Pharm; 2018 Oct; 40(5):1359-1371. PubMed ID: 29611015
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults.
    Kvedariene V, Sitkauskiene B, Tamasauskiene L, Rudzeviciene O, Kasiulevicius V, Nekrosyte G, Gomes ER, Demoly P.
    Allergol Immunopathol (Madr); 2019 Oct; 47(1):32-37. PubMed ID: 30245285
    [Abstract] [Full Text] [Related]

  • 15. Genetic Predictors of Drug Hypersensitivity.
    Cornejo-Garcia JA, Oussalah A, Blanca M, Gueant-Rodriguez RM, Mayorga C, Waton J, Barbaud A, Gaeta F, Romano A, Gueant JL.
    Curr Pharm Des; 2016 Oct; 22(45):6725-6733. PubMed ID: 27779086
    [Abstract] [Full Text] [Related]

  • 16. Drug hypersensitivity in children.
    Lee BW.
    Ann Acad Med Singap; 1991 Jan; 20(1):114-7. PubMed ID: 2029151
    [Abstract] [Full Text] [Related]

  • 17. Controversies in drug allergy: In vitro testing.
    Mayorga C, Ebo DG, Lang DM, Pichler WJ, Sabato V, Park MA, Makowska J, Atanaskovic-Markovic M, Bonadonna P, Jares E.
    J Allergy Clin Immunol; 2019 Jan; 143(1):56-65. PubMed ID: 30573343
    [Abstract] [Full Text] [Related]

  • 18. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC, Smyth AR, Brown M, Jones AP, Hickey H, Kenna D, Ashby D, Thompson A, Sutton L, Clayton D, Arch B, Tanajewski Ł, Berdunov V, Williamson PR.
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [Abstract] [Full Text] [Related]

  • 19. Hypersensitivity reactions to intravenous antibiotics in cystic fibrosis.
    Wright MFA, Bush A, Carr SB.
    Paediatr Respir Rev; 2018 Jun; 27():9-12. PubMed ID: 29703693
    [Abstract] [Full Text] [Related]

  • 20. Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome.
    Elzagallaai AA, Jahedmotlagh Z, Del Pozzo-Magaña BR, Knowles SR, Prasad AN, Shear NH, Rieder MJ, Koren G.
    Mol Diagn Ther; 2010 Oct 01; 14(5):317-22. PubMed ID: 21053997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.